CCT 031374 hydrobromide
CAS: 1219184-91-4
Ref. 3D-UYB18491
5mg | Discontinued | ||
10mg | Discontinued | ||
25mg | Discontinued | ||
50mg | Discontinued | ||
100mg | Discontinued |
Product Information
CCT 031374 hydrobromide is a tyrosine kinase inhibitor that inhibits the c-met receptor, which is a tyrosine kinase. CCT 031374 hydrobromide has been shown to inhibit platelet production and activity by inhibiting the fms-like tyrosine receptor. CCT 031374 hydrobromide may be useful for treating cancer, as it blocks abnormal cell growth by inhibiting c-met signalling in tumor cells.